✦ LIBER ✦

Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, α-interferon, cisplatin (FAP)

✍ Scribed by Shi-Ming Tu; Randall E. Millikan; Lance C. Pagliaro; Danai Daliani; Christos N. Papandreou; Jeri Kim; Dung-Tsa Chen; Dallas L. Williams; Christopher J. Logothetis

Book ID: 117724258
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 75 KB
Volume: 21
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(02)00300-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of FAP (5-Fluorouracil,

A phase I study of FAP (5-Fluorouracil, α-interferon and cisplatin) combined with methotrexate for the treatment of advanced urothelial malignancies

✍ Shi-Ming Tu; Emily D. Robinson; Robert J. Amato; Julie A. Ellerhorst; Robert G. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 632 KB

A phase II trial of methotrexate, cispla

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma

✍ William K. Oh; Judith Manola; Jerome P. Richie; Kevin R. Loughlin; Philip W. Kan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma. ## METHODS. Twenty-four patients

Phase II trial of cisplatin, 5-fluoroura

Phase II trial of cisplatin, 5-fluorouracil, and interferon-α-2B as first line treatment of advanced urothelial cancer

✍ Shouki Bazarbashi; Chandrashaker Pai; Madras A Raja; Mohammad Rahal; Adnan Ezzat 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Interferon α increases toxicity of cispl

Interferon α increases toxicity of cisplatin + 5-fluorouracil in patients with relapsed squamous cell carcinoma of the head and neck

✍ Nicolson, MC; Lorentzos, A; A'Hern, RP; Atkinson, HA; Gore, ME 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Systemic Combined Chemotherapy with Low

Systemic Combined Chemotherapy with Low Dose of 5-Fluorouracil, Cisplatin, and Interferon-α for Advanced Hepatocellular Carcinoma: A Pilot Study

✍ Yasuji Komorizono; Kazunori Kohara; Makoto Oketani; Masahiko Maeda; Toshihiko Sh 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 30 KB

Phase II clinical trial with 5-fluoroura

Phase II clinical trial with 5-fluorouracil, recombinant interferon-α-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus

✍ Scott Wadler; Hilda Haynes; Jonathan J. Beitler; Xiaoping Hu; Stanley Fell; Marg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

## Background: Recombinant interferon-alpha (ifn) augments the cytotoxicity of both 5-fluorouracil (5-fu) and cisplatin in vitro. a phase ii study of 5-fu and ifn resulted in response rates of 25-27% in patients with metastatic esophageal carcinoma. ## Methods: A phase ii trial was initiated to d